Net sales of the next-generation Water Healthcare business: ¥16,990 million
First written in FY2023. 1 of 2 entries say "Achieved", first in FY2024. Latest entry: FY2024.
No other company in this theme has enough history to compare yet.
- FY2024AchievedAnnual report
「Revenue in the Water Healthcare business was ¥17,777 million, up 13.5% from the previous fiscal year,」
Against the previous fiscal year's plan for Water Healthcare business revenue of ¥16,990 million in the next fiscal year, actual revenue for the current fiscal year was ¥17,777 million, exceeding the plan. - FY2023First statedAnnual report
「In the next fiscal year, restrictions on face-to-face sales will be lifted as COVID-19's legal classification was downgraded to Class 5 on 8 May this year, and face-to-face sales are expected to gradually normalize. The Company will work to make the year one of renewed growth beyond a recovery to pre-pandemic levels. It is continuing efforts to refine its sales approach by returning to the basics and strengthen sales capabilities, and aims to sell 5,000 units through workplace sales and 1,700 units through installation and referral sales in June this year. In addition, price increases for the water ionizer units implemented from March and for cartridges from April are expected to boost revenue and support an improvement in the operating margin. The Water Healthcare business is projected to generate revenue of ¥16,990 million, up 8.5% from the previous fiscal year.」
For the Water Healthcare business in the next fiscal year, the Company projected revenue of ¥16,990 million and identified the normalization of face-to-face sales, improvements to sales messaging, sales-force targets and price revisions as means of achieving it.